Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.

Biotechnology

Alchemab Therapeutics

Alchemab Therapeutics' headquarters in London, United Kingdom

Jane Osbourn

Paul Varley

Jenny Howell

Galina Nosovitskaya

Maureen West

Olivia Snudden

Ruth Jones

Sophie Sanford

Ralph Minter

Jake Galson

Alexander Hewitson

Donna Finch

Becky Eretta

Aretas Gaspariūnas

Jorge Dias

Kimberly Long

Raul Tamas

Matthew Kraman

Helen Graves

James McCarthy

Deirdre Flaherty

Malcolm Gates

Martin Butler

Emma Cain

Kate Bingham

Andrew Levin

John Hamer

Kevin Lee

This department focuses on conducting advanced scientific studies and experiments to drive innovation and discovery.

Scientific Research

The Research and Development team at Alchemab Therapeutics focuses on innovative drug discovery by leveraging patient antibodies to develop treatments for hard-to-treat diseases. This multidisciplinary team, composed of scientists, bioinformaticians, and project managers, collaborates to advance research from initial concept through clinical application, ensuring that promising therapies are rigorously tested and optimized for patient safety and efficacy. Additionally, they integrate cutting-edge machine learning techniques to enhance data analysis and accelerate the discovery process.

Research and Development

This department oversees strategic direction and high-level decision-making within the organization.

Executive Leadership

The Project Management team at Alchemab Therapeutics is responsible for overseeing drug discovery and development initiatives, ensuring projects align with strategic goals and timelines. They facilitate cross-functional collaboration among departments, manage resources, and track progress to efficiently bring innovative therapies to market. Their expertise ensures that projects are executed smoothly and adaptively, ultimately supporting the company's mission to leverage patient antibodies in combating hard-to-treat diseases.

Project Management

This department focuses on the analysis and interpretation of biological data using computational techniques.

Bioinformatics

This department focuses on the research and development of biomarkers and emerging biological targets to enhance therapeutic strategies.

Biomarkers and Biology

Alchemab Therapeutics

Org chart

Board & advisors

Teams

Scientific Research

Research and Development

Executive Leadership

Project Management

Bioinformatics

Biomarkers and Biology

Offices

Alchemab Therapeutics

Org chart

Board & advisors

Teams

Scientific Research

Research and Development

Executive Leadership

Project Management

Bioinformatics

Biomarkers and Biology

Offices

Related companies